Current assets decreased 37.2%
Current assets changed -37.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets changed -37.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed -31.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -99.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -29.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed +71.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -496.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -35138 basis points from the comparable as-filed period.
Revenue changed -58.9% from the comparable as-filed period.
Net income changed -23.0% from the comparable as-filed period.
Inventory / revenue changed +23741 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +13.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed +459 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -38.7% from the comparable as-filed period.
Operating cash-flow margin changed -22787 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -13.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed -2022 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed +5.1% from the comparable as-filed period.
Current ratio changed -27.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed +16273 basis points from the comparable as-filed period.
Receivables / revenue changed -3872 basis points from the comparable as-filed period.
Research & development changed +2.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.